A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Clinical trial NCT04738942 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04738942
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-04
- Primary completion
- 2025-05-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.